FUND Sell 11.06.2026 14:08
Pfizer Inc.: analysts at RBC Capital Markets upgraded the stock rating to Market Perform targeting 25.00
Shares of Pfizer Inc., the largest American pharmaceutical company, are trading at 26.00.
TECH Buy 01.06.2026 13:22
Pfizer Inc.: Murrey analysis
In the middle of last month, shares of Pfizer Inc., the largest US pharmaceutical company, resumed growth after a correction within the long-term uptrend.
Indicators
Overall recommendation Wait
Overall recommendation Buy
Overall recommendation Wait
Overall recommendation Buy
Overall recommendation Sell
Overall recommendation Sell
Overall recommendation Wait